Of note, while this work focused on cancer cell intrinsic functions of FAK, this kinase is also expressed by T cells, and inhibition of FAK in this context may sensitize T cells to low affinity tumor antigens and prolong T cell-dendritic cell engagement [128]. The gene discussed is PTK2; the disease is neoplasm.